- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- PKD & Rare Kidney Diseases
- Anemia Due To CKD
- CKD & Related Comorbid Conditions
- Kidney Failure & Kidney Replacement Therapies
- Electrolyte Disorders
- NephU Nutrition & The NephChefTM
- NephU Presents – Hot Topics in Nephrology
- NephU Med Talks
- Presentation Request
- Patient Resources
About This Event
The Role Of The Pharmacist In Neurocritical Care
Hyponatremia is the most common electrolyte imbalance encountered in clinical practice. Defined as serum sodium levels of less than 135 mmol/L or 135 mEq/L, hyponatremia occurs in up to 30% of hospitalized patients.1,2 It is common in intensive care units and neurosurgical care units, but also in patients receiving anti-seizure medications, antidepressants and thiazide diuretics.3 Among hospitalized patients, hyponatremia significantly increases mortality risk, length of stay and cost of care. Severe hyponatremia can lead to cerebral edema, seizures, coma and death.4
Clinical pharmacists significantly contribute to the care of patients with hyponatremia by identifying patients at risk and the source of hyponatremia, monitor serum sodium concentration and advise on the selection of appropriate therapeutic agent, dosage and duration. Many drugs may contribute to hyponatremia; therefore, a careful review of prescribed medications may identify the cause of the electrolyte imbalance and contribute to prompt resolution.
1. Wald, R. et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010; 170: 294–302.
2. Verbalis JG et al. Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations Am J Med. 2013;126:S1-S42
3. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52:144-53.
4. Patterson JH. The impact of hyponatremia. Pharmacotherapy 2011;31(5 Suppl):5S-8S.
*Dr Rhoney is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Lambert is an employee of OPDC.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Hannah N. Lambert is a Clinical & Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.
UNC Eshelman School of Pharmacy *
Denise H. Rhoney, PharmD, is Professor within the Division of Practice Advancement and Clinical Education at the University of North Carolina (UNC) Eshelman School of Pharmacy in Chapel Hill, North Carolina. Dr Rhoney received her Doctor of Pharmacy at the University of Kentucky College of Pharmacy in Lexington. She completed a residency in general clinical pharmacy and another residency in critical care specialty at the Albert B. Chandler Medical Center at the University of Kentucky. She also completed a clinical research fellowship at UNC at Chapel Hill/Glaxo. After completing her fellowship, she spent 17 years at Wayne State University in Detroit, Michigan, working with the Neurocritical Care Team at Detroit Receiving Hospital before coming to UNC Eshelman School of Pharmacy in 2012.
Dr Rhoney is a fellow of the American College of Critical Care Medicine, American College of Clinical Pharmacy, and the Neurocritical Care Society and belongs to many other professional organizations, including the Neurocritical Care Society, where she served on the Board of Directors. She is a member of the Critical Care Practice and Research Network and the Central Nervous System Practice and Research Network of the American College of Clinical Pharmacists, as well as a member of the clinical pharmacology section of the Society of Critical Care Medicine. She served as Chair of the American College of Clinical Pharmacy Research Institute Board of Trustees. Dr Rhoney has been an investigator on numerous clinical trials, many as Principal Investigator.
Dr Rhoney’s research has focused mainly on traumatic brain injury and acute stroke. She has expertise in cerebrospinal fluid pharmacokinetics of pharmacologic agents. She has authored or coauthored 9 book chapters, 5 book reviews, and more than 100 articles and abstracts published in peer-reviewed journals such as Pharmacotherapy, Neurology, and Neurocritical Care. Dr Rhoney is the recipient of numerous honors and awards, including the Presidential Award of Teaching Excellence at Wayne State University and the American Association of Colleges of Pharmacy Innovations in Teaching Award. Dr Rhoney’s current focus is using this strong clinical background and research dedication and translating this to the interface between practice and education.
If you would like to register for the 6:00 pm to 7:00 pm EST broadcast, please click below:
On-Demand Webinar September 14, 2022
Enjoy this on-demand webinar as our leading expert, Neera Dahl, MD, PhD unravels the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and…
Article September 8, 2022
The most emergent, life-threatening extrarenal ADPKD manifestation is intracranial aneurysms (ICAs), learn more about them in this article.
Infographic September 8, 2022
This helpful infographic reviews some of the information pertaining to genetic testing in ADPKD.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
October 18 from 12:00 pm to 1:00 pm
October 18 from 3:00 pm to 4:00 pm
October 27 from 12:00 pm to 1:00 pm
- Resource Center
- Presentation Request
- Patient Resources